calendar
4,017 catalysts · 3,153 8k filing · 577 earnings · 172 phase 2 completion · 133 drug shortage · 98 grant · 73 phase 1 completion
4,017 catalysts · 3,153 8k filing · 577 earnings · 172 phase 2 completion · 133 drug shortage · 98 grant · 73 phase 1 completion
Therapy area: Hematological Disorders. Indication: Anemia, Iron Deficiency Anemia
Therapy area: Oncology. Indication: Nasopharyngeal Cancer
Therapy area: Musculoskeletal Disorders. Indication: Dermatomyositis
Therapy area: Central Nervous System, Non Malignant Disorders. Indication: Benign Tumor, Mastalgia (Breast Pain)
Therapy area: Central Nervous System. Indication: Pain
Items: 5.07, 9.01
Items: 8.01, 9.01
Items: 2.05
Items: 7.01, 8.01, 9.01
Items: 2.02
Items: 1.01, 7.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 1.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 1.01, 7.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 5.02, 9.01
Items: 1.01, 3.02, 8.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 3.02, 9.01
Items: 2.02, 9.01
Items: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Items: 2.02, 7.01
Items: 5.02
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 5.02, 9.01
Items: 8.01
Items: 5.02
Items: 7.01, 9.01
Items: 7.01, 9.01
Items: 5.02
Items: 5.02
Items: 8.01
Items: 2.02, 9.01
Items: 1.01
Items: 5.02
Items: 3.01
Items: 1.01, 3.02, 5.01, 5.02, 5.03, 5.07, 9.01
Items: 3.01, 7.01, 9.01
Items: 8.01, 9.01
Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)
Therapy area: Oncology. Indication: Hepatocellular Carcinoma, Liver Cancer
Therapy area: Oncology. Indication: Cervical Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Esophageal Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Gastric Cancer, Head And Neck Cancer, Head And Neck Squamous Cell Carcinoma (HNSC), Hepatocellular Carcinoma, Hypopharyngeal Cancer, Laryngeal Cancer, Malignant Pleural Mesothelioma, Melanoma, Non-Small Cell Lung Carcinoma, Oral Cancer, Oral Cavity (Mouth) Cancer, Oropharyngeal Cancer, Ovarian Cancer, Pancreatic Cancer, Re